Sight Sciences Statistics
Total Valuation
Sight Sciences has a market cap or net worth of $181.19 million. The enterprise value is $97.91 million.
Important Dates
The last earnings date was Thursday, November 7, 2024, after market close.
Earnings Date | Nov 7, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
Sight Sciences has 50.75 million shares outstanding. The number of shares has increased by 2.48% in one year.
Current Share Class | 50.75M |
Shares Outstanding | 50.75M |
Shares Change (YoY) | +2.48% |
Shares Change (QoQ) | +0.88% |
Owned by Insiders (%) | 19.38% |
Owned by Institutions (%) | 33.94% |
Float | 31.06M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 2.23 |
Forward PS | 2.09 |
PB Ratio | 1.89 |
P/TBV Ratio | 1.91 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 1.23 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 10.18, with a Debt / Equity ratio of 0.37.
Current Ratio | 10.18 |
Quick Ratio | 9.53 |
Debt / Equity | 0.37 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -8.69 |
Financial Efficiency
Return on equity (ROE) is -45.36% and return on invested capital (ROIC) is -21.28%.
Return on Equity (ROE) | -45.36% |
Return on Assets (ROA) | -19.40% |
Return on Capital (ROIC) | -21.28% |
Revenue Per Employee | $371,696 |
Profits Per Employee | -$235,290 |
Employee Count | 214 |
Asset Turnover | 0.50 |
Inventory Turnover | 1.55 |
Taxes
In the past 12 months, Sight Sciences has paid $208,000 in taxes.
Income Tax | 208,000 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +6.25% in the last 52 weeks. The beta is 2.57, so Sight Sciences's price volatility has been higher than the market average.
Beta (5Y) | 2.57 |
52-Week Price Change | +6.25% |
50-Day Moving Average | 4.47 |
200-Day Moving Average | 5.73 |
Relative Strength Index (RSI) | 38.94 |
Average Volume (20 Days) | 234,039 |
Short Selling Information
The latest short interest is 984,571, so 1.94% of the outstanding shares have been sold short.
Short Interest | 984,571 |
Short Previous Month | 977,459 |
Short % of Shares Out | 1.94% |
Short % of Float | 3.17% |
Short Ratio (days to cover) | 3.66 |
Income Statement
In the last 12 months, Sight Sciences had revenue of $79.54 million and -$50.35 million in losses. Loss per share was -$1.01.
Revenue | 79.54M |
Gross Profit | 67.70M |
Operating Income | -49.71M |
Pretax Income | -52.20M |
Net Income | -50.35M |
EBITDA | -49.02M |
EBIT | -49.71M |
Loss Per Share | -$1.01 |
Full Income Statement Balance Sheet
The company has $118.56 million in cash and $35.29 million in debt, giving a net cash position of $83.28 million or $1.64 per share.
Cash & Cash Equivalents | 118.56M |
Total Debt | 35.29M |
Net Cash | 83.28M |
Net Cash Per Share | $1.64 |
Equity (Book Value) | 94.96M |
Book Value Per Share | 1.88 |
Working Capital | 126.67M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$25.38 million and capital expenditures -$512,000, giving a free cash flow of -$25.89 million.
Operating Cash Flow | -25.38M |
Capital Expenditures | -512,000 |
Free Cash Flow | -25.89M |
FCF Per Share | -$0.51 |
Full Cash Flow Statement Margins
Gross margin is 85.11%, with operating and profit margins of -62.50% and -63.30%.
Gross Margin | 85.11% |
Operating Margin | -62.50% |
Pretax Margin | -63.04% |
Profit Margin | -63.30% |
EBITDA Margin | -61.62% |
EBIT Margin | -62.50% |
FCF Margin | n/a |
Dividends & Yields
Sight Sciences does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -2.48% |
Shareholder Yield | -2.48% |
Earnings Yield | -27.79% |
FCF Yield | -14.29% |
Analyst Forecast
The average price target for Sight Sciences is $6.27, which is 75.63% higher than the current price. The consensus rating is "Buy".
Price Target | $6.27 |
Price Target Difference | 75.63% |
Analyst Consensus | Buy |
Analyst Count | 7 |
Revenue Growth Forecast (5Y) | 9.08% |
EPS Growth Forecast (5Y) | -25.23% |
Stock Forecasts Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Sight Sciences has an Altman Z-Score of 0.33 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 0.33 |
Piotroski F-Score | 3 |